Philip Morris International Inc. (PM) Earnings Call Transcript & Summary

April 21, 2020

New York Stock Exchange US Consumer Staples Tobacco earnings 78 min

Earnings Call Speaker Segments

Nick Rolli

executive
#1

Good day, everyone, and thanks for being with us. A press release went out earlier today with full details about how we performed in the first quarter of 2020. That release can be found at www.pmi.com, or through the PMI Investor Relations app. Towards the close of today's webcast slides — which you'll find posted on our site — you'll see a glossary of terms. It covers what we mean by reduced-risk products, or RRPs, along with adjustments, other calculations, and reconciliations to the most directly comparable U.S. GAAP measures, plus additional heated tobacco unit market data and our business transformation metrics. Any mention of IQOS, unless stated otherwise, refers to our heat-not-burn products under that brand. Figures are shown on a like-for-like basis, reflecting pro forma 2019 results, adjusted for the deconsolidation of our Canadian subsidiary, Rothmans, Benson & Hedges, Inc., which took effect March 22, 2019. Remarks today include forward-looking statements and projections of future results. I'd point you to the forward-looking and cautionary statements disclosure in today's presentation and press release, so you can review the various factors that might cause actual results to differ materially from projections or forward-looking statements. Be aware that we now also include additional forward-looking and cautionary statements related to COVID-19. At this point, it's my pleasure to bring in André Calantzopoulos, our Chief Executive Officer, and Martin King, our Chief Financial Officer — both will be available for the question-and-answer session. André?

André Calantzopoulos

executive
#2

Thanks, Nick, and hello everyone. We're all facing a situation the likes of which we haven't seen before, and I hope each person on this call, along with their loved ones, remains safe and healthy. I also want to convey how grateful we are for the tireless, life-saving work being done by frontline staff in medicine, social services, and other essential roles throughout the COVID-19 pandemic. Right now, what matters most to us is the health and wellbeing of the people who work for us, their families, and the communities where we do business; we've put strict protocols and actions in place to reduce danger for those still coming into our sites and offices. For every one of our employees, including those doing their jobs from home, offering direction and assistance is just as important. Not long ago we introduced a fresh set of guiding principles aimed at assuring staff of the Company's dedication to protecting jobs for the duration of the global pandemic, focused on three areas: Employment stability; financial stability; and special recognition. The resilience and character displayed in these difficult circumstances by the individuals who form our organization genuinely inspire me and the Philip Morris International management team, and I want to use this moment to thank them for their remarkable contributions. In fact, our colleagues keep coming up with new ways for themselves and PMI to bring skills and resources to the broader societal response. Initiatives already running or in the pipeline across more than 60 countries involve supplying protective equipment to our trade partners, assisting care communities, offering procurement help to obtain items critical for fighting COVID-19, and giving financial backing to institutions and non-government organizations striving to bring this crisis to an end. On top of that, our employees in numerous countries are signing up to assist elderly, low-income, and other at-risk populations, and a few of our factories are turning out hand sanitizer and masks for the communities around them. Finally, and this is very significant, we've also put measures in place to keep supply flowing to our customers and consumers, and to help our suppliers get through these difficult times. Let me now share my thoughts on how COVID-19 is affecting our business overall and our outlook, before I pass things to Martin, who will go through this impact and the quarter's performance in greater detail. We entered the year with an exceptionally robust first quarter, experiencing only minor interruption to business performance and sustained momentum in structural growth. Although we've seen several temporary closures at various manufacturing sites and some extra complications in our route-to-market, we've triggered contingency plans wherever needed to guarantee adequate inventories and consumer access to our products. Combined with a solid balance sheet and liquidity position, our capacity to generate cash will enable us to keep investing in our business, pay off maturing debt and distribute dividends. Moving to the outlook. The built-in uncertainty in the global economic picture makes predicting things far harder than it normally would be. Since social isolation measures have put day-to-day life on hold for a large share of the world's population, this affects our operating environment for the time being. The most direct consequence is felt in Duty-Free sales because of reduced travel, along with further effects from delayed IQOS user acquisition and regulatory price enforcement in Indonesia. All told, this will probably hurt our currency-neutral results in 2020, and the recent shifts in exchange rates will add even more pressure. Because we can barely see how long lockdowns will last or how far-reaching they will be around the globe, we are pulling our yearly outlook and instead giving quarterly guidance, since visibility there is somewhat clearer. Martin will walk everyone through the main drivers, along with our EPS outlook for the second quarter, when the heaviest hit is expected. We believe the powerful momentum in IQOS user acquisition seen over the past few quarters will pick back up once restrictions loosen. In the interim, our digital and commercial capabilities let us keep serving current adult consumers, make the most of converting adult smokers given today's conditions, and adjust our spending as needed to keep costs optimal. There is also substantial uncertainty about how big the economic fallout from the present situation will be, and about how quickly and in what form a recovery will come, including effects on disposable incomes and joblessness. Though it is premature to gauge fully what this may do to market dynamics regarding consumption and down-trading, we must presume some effect will occur. We also detect, in some developing nations, problems maintaining business continuity for certain smaller general trade participants, which could cause localized out-of-stocks. Still, as during earlier periods of economic and social upheaval, we anticipate delivering resilient results amid these difficulties. Martin?

Martin King

executive
#3

Appreciate that, André.To kick things off, here's a quick top-level look at how we did in Q1 — a quarter that came in extremely robust on a like-for-like, ex-currency growth basis, prior to any effects from the pandemic. In our estimation, COVID-19 impacts — chiefly movements in distributor and trade inventory — contributed 2 points toward net revenue growth, 110 basis points toward adjusted operating income margin, and 6.8 points toward growth in adjusted diluted earnings per share.Shipments of heated tobacco units climbed 45%, reaching 16.7 billion units, driven by ongoing broad-based share gains. On a like-for-like basis, total combined shipment volume slipped by a modest 0.6%, helped along by inventory movements. Net revenues on a currency-neutral basis rose 10%, reflecting both the volume growth and the favorable geographic mix of HTUs, alongside a strong combustible tobacco pricing variance of 7.7%; that vigorous revenue growth, paired with a positive margin mix, scale effects from higher HTU volumes, cost efficiencies and cost phasing, produced a 510 basis-point lift in our adjusted currency-neutral operating income margin, plus 30.1% growth in currency-neutral adjusted diluted EPS.This excellent opening to the year, with encouraging progress across both our combustible and reduced-risk product businesses, matters especially as we weigh the impact of the COVID-19 pandemic.While we anticipate our core existing operations will keep performing well, three main areas stand out where temporary shifts in our operating environment should leave their mark, on top of the currency movements I'll return to shortly. The first, and probably the longest lasting, concerns Duty-Free sales, given how severely global travel has been curtailed. For context, PMI Duty-Free holds a market share of 37% and contributed almost 4% of our 2019 net revenues. It also benefits from higher unit margins than the global average, owing to its skew toward premium brands like Marlboro and HEETS. Consumer offtake trends finished March with declines of over 80%, and we anticipate similar patterns persisting until travel begins to recover.Given the premium skew of our Duty-Free sales, we assume only a portion of that volume will be picked up by our own brand portfolio in local markets, typically at lower margins.The second impact concerns the pace of IQOS user acquisition. Efforts to contain the virus, along with similar limitations, make it harder for us to reach adult smokers. In several markets, our IQOS retail touch-points are closed right now, and in places where they haven't shut, customer traffic has fallen sharply. The money we've put into digital capabilities during recent quarters is paying off, and where necessary we're moving more commercial spend into digital channels. Although our commercial sales experts and coaches have very few chances to interact with consumers in person, they can still use various tools to run virtual guided trials. Even so, looking at what's happened since lockdowns began, we figure new users will come in at roughly half the pace we'd originally projected, and that will hold true as long as broad restrictions stay in place. It's also hard to forecast the geographic blend, since different countries are behaving differently. Let me be clear: we view this as delayed expansion, not lost expansion, and we think the strong underlying momentum from recent quarters will pick up speed once the restrictions come off. A key point is that our digital capabilities mean we don't expect any impact on keeping customers or on conversion rates. To give you a sense of the scale, each additional 1 million users we bring in translates to about 5 billion heated tobacco units on an annualized consumption basis. If you apply the pre-COVID market mix — which factors in device sales along with cannibalization effects — that works out on average to over $350 million in net revenues and over $200 million in incremental contribution. We also have room to adjust our commercial initiatives. That means the timing we've planned for IQOS VEEV, our improved e-vapor product, as well as the licensed KT&G products, both slated for later this year, may get pushed back depending on how things develop. Indonesia is the final major area where we're seeing an impact. As we've said before, 2020 was already a year focused on catching up on excise tax and pricing. One structural upside of the new excise tax was that the increase was bigger, in percentage terms, in the mid-to-low section of the market, and a new minimum retail selling price was set to take effect on April 1st. But the government has now announced that enforcement of that new minimum price won't begin until June, because of COVID-19 restrictions. Having these unfavorable price gaps last longer adds another headwind — it raises the risk of down-trading, affects when we can raise prices, and affects our market share. The impact of pandemic-related measures on the environment we operate in, such as travel restrictions, is clear, but there is more uncertainty about how the crisis will affect consumer purchasing behavior socially and economically. In places with robust social safety nets—think the EU or Japan—the effect we've seen up to now has been fairly small. A few markets did see pantry-loading when restrictions first came in. Still, those episodes tended to fade quickly and barely moved Q1 results, since shifts in distributor and trade inventory mattered more. Elsewhere, in some developing markets, the fact that so many people earn daily wages, combined with fewer resources for social support and therefore incomes that are more fragile, leaves them more exposed. In a number of countries, we're picking up early signals of down-trading and lower daily consumption. Indonesia and the Philippines stand out as the biggest ones for us, and the Philippines brings an extra element since it operates as a stick market. Our assumption is that these patterns will persist for a while, for as long as restrictions tied to the pandemic remain in place. Like André said, because route-to-market infrastructure is less developed in some places, we also pick up on possible hurdles in certain emerging markets affecting some of the smaller general trade outlets, and that could result in short-term out-of-stocks confined to particular areas. When it comes to our own manufacturing and distribution, things keep running smoothly even with the obstacles we face right now. That's thanks to the phenomenal work of our supply chain and market teams, who have put several contingency measures in place covering production and customer supply. Generally speaking, our product inventories are in good shape: heated tobacco units are at more than 2 months, IQOS devices at more than 3 months, and cigarettes, distributors included, at more than 1.5 months. Following a 1-week production halt in late March at our Bologna HTU plant, every one of our HTU factories is now running with enough capacity. Temporary shutdowns are presently impacting roughly 20% of our cigarette production capacity. Even so, we don't see any out-of-stocks right now in major operating income markets. One thing to watch is Argentina, where out-of-stocks will hit us if the factory doesn't restart soon. Given that liquidity of publicly traded businesses is top of mind for investors right now, I want to highlight where we stand, which is quite solid. We continue to have plenty of sources of liquidity through the cash our operations keep producing, the cash we hold, and our ability to tap commercial paper. The $7.5 billion revolving credit facility has not been drawn upon. Our balance sheet remains healthy, featuring bonds with staggered maturities and net debt equal to 1.9 times adjusted EBITDA as of March 31, 2020. In the first quarter, bonds totaling $3.6 billion reached maturity and were paid off, and across January and April, shareholders received dividends amounting to $3.6 billion. Additionally, we anticipate robust cash generation that will surpass what we need for cash obligations—among them covering dividend payments, and we're still fully dedicated to those. There's no impairment whatsoever to our capacity for making suitable investments in the business and paying down debt.

Martin King

executive
#4

But it's possible that paying down our balance sheet further, using the exchange rates we see now, could take a bit longer than we’d thought before. I should also note that our cost efficiency efforts are still underway, and we’re still very much on course to achieve more than $1 billion in savings by 2021; those initiatives are adaptable too, and we’re shifting priorities as circumstances change. On that note, we anticipate cutting capital expenditures to roughly $0.8 billion this year, and that decrease has nothing to do with RRP investments. Now let’s move to guidance. During the call, we noted—just as in the release—that the diluted full-year 2020 EPS outlook we previously reported, at least $5.50, has been withdrawn. Absent COVID-19, it was evident our business would have reached that figure; however, given where we are today, there is simply insufficient certainty about the duration and extent of lockdowns and social distancing measures, nor about their wider consequences, to offer a full-year earnings projection with adequate reliability. Because near-term visibility looks somewhat stronger, we are offering quarterly guidance instead, looking just one quarter ahead. As mentioned before, we had already expected a weak second quarter, owing particularly to a tough year-over-year comparison, conditions in the Indonesian market, and the timing of costs. Additionally, we anticipate that this timeframe will bring the biggest three-month impact on our operations stemming from the COVID-19 pandemic, and that has been included in our calculations. As a result, our forecast for reported diluted EPS in the second quarter of 2020 falls within a range of $1 to $1.10; this estimate incorporates a $0.12 drag from foreign exchange at current rates, mirroring how numerous currencies in the markets where we operate have weakened relative to the U.S. dollar. We also factored in currency headwinds, particularly from the ruble in Russia, the rupiah in Indonesia, and the peso in Mexico. Inventory movements contributed $0.10, largely from reversals tied to the first quarter. Lost Duty-Free business, after accounting for domestic sales recapture and assuming global travel stays depressed throughout the period, added $0.09. Finally, $0.05 to $0.15 came from the postponed enforcement of minimum pricing in Indonesia along with other COVID-19 effects, such as short-term declines in daily consumption and consumers trading down in some developing markets. Our assumptions further anticipate ex-currency net revenue falling roughly 8% to 12%, and that decrease is expected to stem entirely from COVID-19 related impacts, device sales included. I'd like to take you through a few of the main highlights from how we did in Q1. Our estimate is that the overall international industry shrank by 2.9% during that stretch. Even so, our own like-for-like shipment volume was down only 0.6%, and within that, cigarettes dropped 3.8% — something that was mostly balanced out by heated tobacco units climbing an impressive 45.5%, with the EU region, Japan and Russia making noteworthy contributions. If you set aside the net favorable effect from estimated distributor inventory movements, our total in-market sales volume came in 3.7% lower. Two things mainly drive those inventory movements: first, the comparison to a year earlier, when Q1, 2019 shipment volumes sat below in-market sales; and second, a net build-up of distributor inventory during Q1, 2020 aimed at reducing the risk of disruption tied to COVID-19. On the call, we noted that in-market sales for our HTU product rose 3.9% from the fourth quarter to the next, topping 17 billion units during what is usually the year's slowest period. Given that strong performance, heated tobacco units now account for nearly 10% of our total shipments — that's up from 8% in 2019, and essentially nothing in 2015. We expect that portion to keep rising as momentum for our RRPs remains favorable. Turning to the numbers: net revenues climbed 10% in currency-neutral terms, driven by combustible pricing, a simpler year-over-year comparison with Q1 2019, and growth in heated tobacco units. We figure the COVID-19 impact — more trade inventories plus, to a lesser extent, people stocking up their pantries — made up about 20% of the increase in net revenues, operating income and EPS. Our combustible tobacco pricing variance came in strong at 7.7%, with no real COVID-19 effect and significant input from the GCC, Germany, Mexico, the Philippines, Russia and Turkey. Adjusted operating income rose 25.5% excluding currency, and our currency-neutral adjusted operating income margin grew by a superb 510 basis points; that margin improvement was driven by RRP scale effects and a beneficial geographic mix for HTUs. Additional factors include combustible pricing, cost phasing and the underlying benefit of our cost initiatives. Adjusted diluted EPS grew strongly, up 30.1% excluding currency; on currency, we should note that the unfavorable $0.13 impact in the first quarter includes $0.07 of transactional impact from March, mainly from revaluing euro or dollar denominated payables in certain markets, like Russia, where the local currency has devalued significantly. Those effects would only show up again in later quarters if there were further sharp devaluations. RRP net revenues hit $1.6 billion, or nearly 22% of PMI's total net revenues, with IQOS devices making up about 10% of RRP net revenues. Now to market share. Our total international share came in slightly lower at 27.9%, with heated tobacco units gaining share to reach 2.9%, offset by cigarettes losing share. Cigarette share in our portfolio dropped 1.1 points. That mirrors grown-up smokers continuing to switch over to IQOS, plus notable share decreases in Argentina and Indonesia tied to price gaps against local rivals enjoying tax advantages, trade inventory shifts in Pakistan, and a tough comparison to the prior year in Turkey. Turning to Indonesia: first-quarter industry volumes slipped just 0.6% owing to trade loading effects, which we expect will flip in the second quarter. We raised prices across all major premium and mid-price brands, and PMI's increases since October 2019 account for roughly 85% of the weighted-average pass-on from the 2020 excise hike. Even with premium A Mild bouncing back because price gaps with brands competing directly against it narrowed, our share still went down. The upside we saw got more than offset by what happened with our mid and low-priced brands. They were losing ground to super-low price manufacturers, and those players enjoy tax advantages because their scale is smaller. As a result, when enforcement of the minimum selling price gets pushed back, that stretches out this short-term pressure on share. Another factor is how common daily wage workers are in Indonesia, which adds some unpredictability around how social restrictions will affect everyday consumption. Given all that, we have to say the market's overall decline will end up bigger than the 6% to 7% range we'd forecast earlier. Let's turn now to how RRP is performing. Our estimate puts total IQOS users at 14.6 million as of March 31st, which means we've added over 4 million adult users relative to the same point a year earlier. We also estimate that among that total, 73%, or 10.6 million IQOS users, have quit smoking and made the switch to IQOS, while the rest are at differing stages of conversion. This shows broad momentum in user growth everywhere IQOS matters, such as Japan, Russia and the EU. When it comes to overall share performance, IQOS HTUs keep making outstanding progress. During Q1, IQOS heated tobacco units were again the number-three tobacco brand across the international markets where IQOS is sold, with a 6.6% share, compared with 5.5% in Q4 2019. We achieved that despite not having full national distribution in a fair number of markets. In the EU region, HEETS took 3.9% of total industry volume in Q1, and we figure 0.2 points of that reflected consumers stocking their pantries; on a sequential basis, share gains were similarly strong, up 0.7 points, and in-market sales volume was 13% higher than Q4 2019, despite that quarter typically being softer.

Martin King

executive
#5

You should also check the appendix, where we break out shares for major EU markets and key cities worldwide. In Russia, IQOS kept up its robust momentum, as HEETS share climbed 3.5 points to hit 6.5%. Looking sequentially against the fourth quarter of 2019, HEETS share rose 1.5 points, and in-market sales were up 3%. Because social restrictions in Russia were limited during this period, we estimate pantry-loading had only a minimal effect. Turning to Japan, our total reported share for heated tobacco units rose 2.1 points to 19.1% in the first quarter, helped by the introduction of IQOS 3 DUO along with line extensions across our Marlboro HeatSticks and HEETS ranges. Under an adjusted total tobacco framework that includes cigarillos and is adjusted for trade inventory movements, the share held by our HTU brands rose 1.1 points from the same quarter a year earlier and 0.6 points sequentially, reaching 17.7%. For Q1 2020, adjusted in-market sales volumes for our HTU brands rose 6.2%, while the adjusted total tobacco market fell by roughly 1%. That contributed to pushing the entire heated tobacco category up to a first-quarter total tobacco share above 24%. Finally, after the 2019 U.S. launch of IQOS via our commercial arrangement with Altria, we filed a supplemental PMTA for the IQOS 3 device with the FDA in March, aiming to further support efforts to convert U.S. adult consumers who would otherwise keep smoking. The FDA's review of the Company's Modified Risk Tobacco Product applications for the IQOS tobacco heating system, which is distinct from this PMTA application, is ongoing. I'll now turn things back to André for closing remarks. André?

André Calantzopoulos

executive
#6

Thanks, Martin. To sum up, the strong underlying momentum our business keeps showing, particularly the remarkable expansion of reduced-risk products, once more comes through in the results for the first quarter. The world has plainly shifted now, and there is substantial uncertainty around how the pandemic will develop and how long it will last, along with its economic and social consequences, among them the effects on the environment we operate in and on our consumers. Our business has a track record of proving remarkably resilient, and we think a solid performance is achievable despite today's difficult circumstances. Just as importantly, we stay confident about our structural mid-term growth prospects, and once these headwinds are behind us, we expect growth to resume in line with our 2019 to 2021 compound annual ex-currency growth targets of at least 5% net revenue growth and at least 8% adjusted earnings per share growth. Critically, our organization, our liquidity and our balance sheet are all strong. We will go on protecting and supporting our employees, serving our consumers and rewarding our shareholders, and that clearly takes in our strong commitment to our dividend. We stay resolute in our strategy for a smoke-free future and are convinced we'll come out of this crisis stronger. Thank you. Martin and I are happy now to answer your questions.

Pamela Kaufman

analyst
#7

Hello, and thanks for taking this. I trust everyone is in good shape.

André Calantzopoulos

executive
#8

Hello there, Pam.

Pamela Kaufman

analyst
#9

Hi. I was hoping you could tell us where the biggest effect on growth in new IQOS users is showing up during 2020. And do any markets stand out as surprises when it comes to how well IQOS has held up against the current backdrop? Then, on a separate note, is there a negative effect on usage of IQOS among people who already use it?

André Calantzopoulos

executive
#10

Okay. Let me spend a moment providing some context regarding what we plan to talk about on this call. Okay? First, we don't perceive any sort of structural issue with business fundamentals. What we're seeing is more delays and slowdowns, as you said, in acquisition, plus one-offs while the pandemic lasts. Second, we've assumed that in this quarter, since that's all we can observe, lockdowns will keep going essentially until the end of April and the vast part of May, with some gradual recovery during the month of June, and then it continues. Okay? So, that's important to keep in mind when we talk about the context. So, what we observe with a high degree of certainty is that Duty-Free impact because there's essentially no traveling worldwide. The second thing we've seen, to your point, Pam, is a slowdown in the acquisition of IQOS. That varies market to market obviously because some have stricter restrictions and others much less; so, we have big differences I would say between Japan, who are almost operating with normality with some slowdown and Europe, where we have more slowdown as physically our coaches cannot engage with people and our stores are closed today. So, that's why I'm saying on average we are around 50%, sometimes higher. Okay? So, I find this, given the circumstances are that the people are confined at home to be very resilient actually, especially since as I said, stores are closed and the coaches cannot physically interact with people, and that's the right thing to do. We see a much bigger increase — a high sales through our digital channels. And as Martin said, we're gearing more and more resources from the other channels obviously to those. That's for acquisition. For retention, we don't see any problem. Actually in certain markets, we see people increasing average daily consumption and retention rate and some of dual use being reduced during this period. So, there is no issue from that perspective; and we don't have also an issue regarding the sales of IQOS, heat to tobacco unit in the market. So, I don't know if I answer your question.

Pamela Kaufman

analyst
#11

Yes. Thank you.

Martin King

executive
#12

Let me build on what was just said. Pam, another thing is that conversion rates haven't fallen off at all. As a matter of fact, they look really robust. So keeping customers and converting them — the core business — is going very well. Of course, meeting people in person has become a bit harder, but we're moving over to digital channels as quickly as we possibly can.

Pamela Kaufman

analyst
#13

Thank you; and next, what's the right way to view the relationship between the cost savings you expect to achieve during this year and the money you're putting into the business to encourage IQOS adoption? Is anything holding up those savings? And also, I suppose, what's your thinking on how the timing of your investments might shift, and what areas you're funding?

Martin King

executive
#14

The initial principle behind what we've done is that our spending has to fit the new circumstances. To put it another way, if anything, we're directing additional funds toward the areas that will assist us in regaining momentum and returning to growth the moment the lockdown is over. That's why the emphasis is on places where we can direct more investment, such as digital, and on the initiatives that will deliver a larger effect down the road. That said, we've clearly reviewed our projects too, in order to identify the ones that our current inability to operate is holding back and that must be rescheduled, shifting some of that spending to later in the year or perhaps into the following year. And we've taken another look at our project list, ranking the ones that perhaps delivered a weaker return, and attempted to soften a portion of the consequences of what the COVID-related situation is producing for us. So, all in all, our cost savings remain on track. If anything, we'll speed up certain ones where we're able. And beyond that, the investment side is likewise adjusting to the new circumstances and delivering the greatest value for every dollar we spend; so, we're taking the long view and aiming at the growth momentum we can achieve once we emerge from this.

Pamela Kaufman

analyst
#15

Thanks.

Adam Spielman

analyst
#16

Hi there. Many thanks. I have three items to ask about, if that's alright. The opening one concerns illicit and cross border. So, I'm somewhat taken aback — or let me put that differently. My expectation had been that tougher enforcement at borders and on transport would lead to significantly lower illicit volume additions, plus legal cross border as well. And I would have assumed that would deliver a fairly favorable effect in Q2 and Q3. Yet, nothing about that came up from you. So, I suppose, is my thinking off, or is that a favorable effect? What's the right way to frame this? That's my first item.

André Calantzopoulos

executive
#17

Alright. Once more, Adam, certain of these matters that we attempt to set out rest on what we observe. And you're correct. Some reduction in illicit trade is being reported by our markets, for the reasons you cited. Now, we cannot cautiously take the European Union has 10% illicit trade and say this is going to all disappear and appear in the domestic market. So, we may see some, but — and reasonably so. But, I'm not sure we have taken this all in the number because we are just three weeks essentially in the month of April. And I prefer to remain a bit cautious. But you are right. We are observing this and we should see some impact.

Adam Spielman

analyst
#18

Alright, that helps a lot. Moving on to Indonesia. Clearly, a floor price was set to take effect on April 1. You've mentioned since then that it's been pushed back to June, though I noticed no exact day was provided. Could it happen — or what are the odds in your view — that it gets postponed again, say if Indonesia ends up in a fairly severe recession?

André Calantzopoulos

executive
#19

Let me ask — broadly speaking, here's what we understand: the government stated that since they can't dispatch inspectors to physically check outlets given COVID, a postponement is necessary, and they provided a date, which is June. No specific day within June was given, however. So should they exit this situation or the restrictions sooner, my assumption is they'd act sooner. Should it drag on, then it might stretch out somewhat longer. That's the reason uncertainty exists here as a general matter; at this point, I'm not sure — Martin, would you like to add anything?

Martin King

executive
#20

That's precisely correct. The question is just timing—when they're able to get people on site and begin the inspections. It isn't that they're unwilling to do it. It comes down entirely to the problem they're having with their inspectors.

André Calantzopoulos

executive
#21

Turning to Indonesia now — clearly it belongs among those developing markets. Both Martin in his comments and I noted that a great number of people essentially earn wages by the day. When work is unavailable to them, their spending plainly must shift in response to circumstances. Consequently, we must presume there could be an effect on consumption stemming from COVID as well. Other markets in Southeast Asia might feel it too, and Africa likewise. So we are watching this development, and within our figures we were required to build a projection of just how large that effect will be. As all of you understand, that is quite hard to do. Take a market that is very familiar to us, the Philippines, for instance: this lockdown evidently influences everyday purchasing there too. Furthermore, it is an extremely fragmented trade with tiny operators, who at times find themselves with nothing on the shelf. And consider markets where stick sales apply — with typical stick consumption of 9 sticks each day, dropping to 8 amounts to a 10%, 11% short-term hit on the market. How exact can we be about this? I have no idea, which explains why we provided a wide band for these regions. I believe a portion of it will materialize. Nobody will be shielded from the lockdown. That is the reason we attempt to incorporate certain figures. And at this point, assuming so strikes me as sensible. Should things turn out better, then better.Third question?

Adam Spielman

analyst
#22

To build on what André said — I keep hearing two different stories. I'm setting Europe aside here, since that region is clearly far more profitable for you. Some folks claim that people stuck at home are lighting up more — they feel anxious, they feel bored, and since they aren't traveling, they end up smoking more. Then I hear others say they're smoking less, because they worry about how it might affect their chances of catching this disease. Do you have a take on what individual consumption will look like? I mean developed markets rather than EMs during the lockdown.

André Calantzopoulos

executive
#23

In developed markets, consumption hasn't shifted at all, from what we can tell. Bear in mind it's early, and we lack granular consumer research data. Still, every factor you listed is valid. In a technical sense, those staying home — the ones who normally work in offices — have more chances to smoke than they would at the office. That said, we shouldn't overlook that in some countries you're surrounded by family and children, so you must show a bit more restraint; one effect may offset the other, which explains why the pattern looks unchanged right now. But we should all recognize, folks, that we've lived through plenty of crises and hard times. Even so, having everyone confined at home and never going out is unlike anything we've ever dealt with. Certain shifts in daily consumption could occur. I doubt it touches structure or anything of that sort. We know cigarettes bounce back in markets following a crisis, yet on this particular point I have no experience that lets me be surgically precise. Everything you laid out is accurate. And moving to developed markets — developing markets, rather — we did observe in certain countries, as I mentioned, greater IQOS use at home, right, since people show more consideration toward families and children and so forth; that's the current state in developing markets, as I noted. Alright. We should also keep in mind that in certain cultures, smoking in front of parents, and for some women, may make them less — more hesitant to consume fully. As you point out, that gets offset by additional opportunities, obviously. So on balance, that's the finest estimate available to us at present. I'm doing my best to be fully transparent about what we know at this point.

Adam Spielman

analyst
#24

Adam, thanks so much. One last thing, and I'll keep it brief. You're not providing EPS guidance for the entire year — I understand that, and I appreciate the openness. Still, could you tell us what the currency effect might be? In other words, do we simply take the $0.13 from Q1 along with the $0.12 you've given for Q2, then assume two more quarters at $0.12 each? Is that the right way to think about how FX plays out over the whole year on EPS?

Martin King

executive
#25

Martin, that's quite near the Q2 figure of $0.12. At the exchange rates we're seeing now, Q3 and Q4 should come in around that same level — $0.11 to $0.12, roughly along those lines.

Vivien Azer

analyst
#26

I appreciate the thorough remarks. I'd like to circle back with André regarding a few of the things you said about down trading. Clearly, this varies from one market to the next. Still, I'm wondering: in any market where it's been quite evident, has that shift occurred more quickly than, for instance, during the last financial crisis, or in an Asian market compared with SARS or some other sort of market disruption you've witnessed? Thanks.

André Calantzopoulos

executive
#27

Well, to begin with, the sole instance of down-trading we can point to is the ongoing situation in Indonesia stemming from the price gaps. Alright? In my view, some of it could occur. Now, on one hand, you could argue that certain people, should they experience reduced disposable income for a stretch of time — and I'm still talking about developing countries — might trade down temporarily. On the other hand, we understand that during uncertain periods, particularly the present one, consumers gravitate toward trusted brands from reliable sources, and they lean toward familiar names. So, that runs counter to what I just said, and you have to strike the proper balance. The same applies to illicit trade. It isn't solely about illicit trade being available; a lack of trust in where illicit trade comes from can also curb it. That's because there's this inclination to purchase what's necessary and what's trusted; so, I expect a certain amount of down-trading. I'm not claiming I've observed it. Alright?

Vivien Azer

analyst
#28

That helps, thanks. Now, when you consider the sequential guidance you plan to provide, Martin, it sounds as though you're deliberately being cautious about volumes and shifts in per capita consumption. Could you say anything about the assumptions on price elasticity that sit behind your 2Q EPS guidance? Thanks.

Martin King

executive
#29

Yeah. Take the second quarter, for instance — we'd already anticipated a fairly soft Q2 because of what was going on with how we were lapping pricing in Turkey, where you'd seen large market gains in earlier comparable periods set against a 40% price increase we've made since then; then Mexico, with the price increase landing at a different time and the trade inventory we were managing acting as quite a significant headwind. We'd also already examined Indonesia; we knew the major effect would arrive in Q2. So if you break down the Q2 guidance we're providing, it's genuinely what we'd anticipated beforehand, purely the COVID-related portion. Absent COVID, we'd have finished the first half right on track with our full year figures and reached 9.5%, 10% EPS growth, exactly in line with what we'd expected to deliver for the full year. So then, looking ahead and asking what we'll do for the remainder of the year, we're essentially going to give you one quarter at a time, one quarter in advance, covering what the COVID-related impacts are and attempting to adapt to fresh news about lockdown timing and consumer recoveries and so on. That struck us as the more prudent path, since the underlying business is in fine shape, or performing precisely as we'd thought. Yet predicting how this COVID-related element will play out is very hard; so we can't truly offer you the full-year picture at this point, though we can give you each quarter ahead as best we forecast what will occur based on the latest news we have.

Vivien Azer

analyst
#30

Got it. And a quick follow-up on that, after which I'll go back to the queue. When you consider the impacts tied specifically to COVID for 2Q, are you building in a worsening of price elasticity, simply because of some of the possible headwinds facing the consumer, with the unemployment rate?

Martin King

executive
#31

No, we do have some — like André said, we do have certain watch-outs in there, regarding average daily consumption, regarding down-trading in certain markets. But it isn't truly a matter of price elasticity. When it comes to pricing — the timing of price, we must keep in mind that during lockdowns and at certain moments, it might not be sensible to implement some of the pricing at precisely the same moment we had in the initial plan. So, we'll need to examine when pricing happens in certain markets. In certain markets, we'll probably have to push back some planned pricing. Conversely, we'll scan ahead across the year and see what we can do to try to offset that. So, it's more about the timing of price increases that must be rephased and rescheduled; and there may be — there likely will be somewhat lower overall pricing across the year than what we had initially planned, simply because you run out of runway, as you lose some of the windows because of the lockdowns, et cetera. You run out of runway to recover some of the pricing that you won't be able to take over the next, let's say, couple of weeks, months owing to lockdown.

André Calantzopoulos

executive
#32

At this point, these are just assumptions, but in my opinion they don’t have to do with price elasticity. It comes down to whether you proceed, and whether governments will permit a price increase in one or two markets in the middle of a crisis; psychologically, from the consumer’s perspective, I don’t believe that’s the right thing to do. So that means a delay of a month or a couple of months. Yet in the great majority of markets, we observe no price elasticity over the short term. Now, over the long term, I can’t predict what COVID’s effect on the global economy will be. However, should world GDP decline significantly over a longer stretch, you might have to revise elasticities; but as you’re aware, with cigarettes, revisions to elasticities are extremely uncommon, unless there is a very large price increase.

Gaurav Jain

analyst
#33

Alright, I've got two things I want to ask about. First, regarding your supply chain and the inventory positions across your factory network — do you believe this current crisis reshapes how you'll approach those matters over the long haul?

André Calantzopoulos

executive
#34

Great question, and it isn't something that's unique to our Company. Right? I've mentioned this on numerous occasions. Being resilient means having a certain amount of slack built into the system overall; and fortunately, we were holding inventories and we had plans in place to deliberately accumulate stock, so we anticipated the crisis coming along with materials and all the inputs required to make that happen. I can't say the same holds true for every company relying on just in time deliveries and attempting to — so, I believe there's a lesson in this for everyone.As you're aware, within our industry, like I mentioned, we keep rather substantial tobacco stockpiles, which is inherent to what we do, and we possess both the ability and the adaptability to accumulate adequate inventory. At this point, I don't foresee anything that ought to be changed regarding our footprint, particularly since with cigarettes, trade blocks and input duties constrain us. So, we consider it pretty much optimal; however, as a precaution, since I doubt COVID is going to vanish overnight — it will resurface — we must remain cautious that this could happen again on the same magnitude as it did this time, because as humanity, we were completely unprepared for it. Still, we need to draw our own lessons about how to inject even greater flexibility into the system. Up to now, I believe we've performed quite well. And you can't see what goes on behind the scenes to keep everything moving. In my view, the people at the Company have worked miracles, all things considered.

Gaurav Jain

analyst
#35

Alright. My following question concerns how IQOS devices are priced. In a downturn, do you believe that the initial cost could turn into a barrier when it comes to bringing in new users?

André Calantzopoulos

executive
#36

Well, naturally we have the ability to tweak prices whenever it becomes necessary, I believe. In my opinion, price does matter when it comes to gaining IQOS customers. That said, as I've stated on numerous occasions, a great deal of it is about persuading individuals to take that step; and at times price serves as the justification. Should you recall what we said back in February, the sole market where we genuinely observe that a tiered approach to device pricing is needed — and at some point also for consumables — is Russia, where in particular cities we are truly hitting the ceiling of the premium buyer. And we're accomplishing that with IQOS 2.4 plus sitting at the lowest point of our lineup, even though it costs more than every rival product. Yet as we've consistently maintained, we keep flexibility around this and are able to make adjustments quite swiftly once business picks back up. Right now, that isn't our problem. What troubles us more is the constrained capacity to engage with customers and at the point of sale.

Gaurav Jain

analyst
#37

Alright, and let me just squeeze in one final question. You've provided a range of $0.05 to $0.15 EPS impact stemming from the delay in minimum price enforcement in Indonesia along with COVID-related costs, which includes down-trading. So, am I right to interpret it this way: the $0.05 represents the effect of minimum price enforcement, since that's something you can see clearly, while the remaining $0.10 in the range comes from down-trading and other COVID costs, because those lack visibility?

André Calantzopoulos

executive
#38

I'd suggest viewing this as a single whole instead of attempting to break it apart, since I don't possess truly precise science when it comes to dissecting it. So it remains an estimate. That said, as I mentioned, even examining the other figures involved — take inventories, for instance — we assumed regarding inventories that the safety stock buildup we carried out in certain countries during March would be entirely paid back. Well, that might not occur, and we've also observed inventory reductions in some countries and Duty-Free, since retailers grew somewhat anxious about the situation, and those won't be recovered by us within the quarter. So we likely incorporated the worst-case scenario to stay on the cautious side. However, these are all things that can be adjusted flexibly. I'm unable to forecast their timing. So, as I said — and I'll repeat — we're aiming to be as transparent as we can right now, given how uncertain things are. And I'll leave it at that, because if I venture any specific figure, I can only end up being wrong.

Chris Growe

analyst
#39

Hi everyone, trust you're doing fine, and it's good to know you're staying safe and well. If I may, I'd like to ask something right off the bat. There's been a seasonal pattern in what you ship across Q1, 2Q, and 3Q. What I'm wondering is how things like social distancing and isolation might influence the usual seasonal bump that shows up in the second quarter. I believe you said daily consumption rates aren't changing much. Might that shift down the road, should these social isolation measures stay in effect?

André Calantzopoulos

executive
#40

Well, as is well known, Q1 is the weakest quarter for consumption of any tobacco product. Right? So when we examine IQOS in-market sales, we have to view them in that light, by definition. Okay?

Chris Growe

analyst
#41

Yes.

André Calantzopoulos

executive
#42

So because of that, the way I see it, they’re actually stronger than what the figures show when you look at them in absolute terms. All right?

Chris Growe

analyst
#43

Sure.

André Calantzopoulos

executive
#44

As for what will happen in Q2 beyond what I already described, I can’t say — across most markets, we aren’t seeing any shift in average daily consumption, apart from the developing markets with those specific circumstances I brought up. We haven’t measured it. And it’s really hard — take a market such as Philippines. Right? Yes, sales have dipped a bit right now. That could be partly about average daily consumption, since it’s a stick sales market and people have less money on hand. It could also be that certain areas ran into temporary out-of-stocks, because it’s a cash economy where many retailers go to wholesalers to make purchases. And before the whole system recombines and works properly again, some time is needed. So I wouldn’t pin the lower sales, if you like, on average daily consumption. But I do have to assume that when people lack a job for a stretch of time and can’t earn their daily salary, for a period they’ll purchase less. In my example I put it this way: okay, if average daily consumption is 9 cigarettes in stick sales and it drops to 8, for a month or for weeks that’s a big difference. Right? That’s my view of it.Now, supposing we emerge from the crisis gradually starting in June, we ought to see things returning. Right? And probably the economy that can bounce back quicker in this casual economy, because it will simply — once people’s limited ability to move and conduct business as usual resumes, I assume we’ll get it back. Now, as I said, the question is temporary. And how temporary temporary is, we don’t know. It’s not unlikely that worldwide we’ll see governments ease up, because the health system is now reaching a point where they can handle a rising number of cases. But six months from now we may hit another slowdown. God knows. Right? That’s why we said we’d provide quarterly reviews. And as we move forward, should we have any better data for the forthcoming shareholders meeting, we’ll update you as well — we’re learning as we speak.

Chris Growe

analyst
#45

Of course.

André Calantzopoulos

executive
#46

Yet I’m not seeing any structural impact — that’s my point.

Chris Growe

analyst
#47

Yeah, thanks for that explanation. It was really helpful. I’d like to ask really fast about what you expect for Q2 — you mentioned IQOS devices, with device sales declining. Did you have significantly more users compared with a year earlier? You don’t anticipate adding as many users either, I understand that. But I was attempting to figure out why your device sales would decline in Q2. Is that simply because of fewer additional users, or are there some returns or something like that happening too?

André Calantzopoulos

executive
#48

Well, the main reason is reduced acquisition across that timeframe. Right? Also, like I mentioned, since device lifespan goes up as time passes, we see fewer replacements. But obviously, throughout this timeframe, our emphasis has been — and we shifted some of our sales experts — if a device has an issue, we move those personnel to handle delivery and consumer service. So, we don’t face a problem on that end. And I believe we’re performing quite well in that regard. I think it’s basically tied to reduced acquisition, which we had anticipated might occur.

Chris Growe

analyst
#49

All right. A quick follow-up — I’d just like to get a handle on this. Inside the guidance you’ve given for the next quarter, Q2, there are presumably reduced expenses too, right? Perhaps less travel, maybe lower SG&A, that sort of item, plus obviously you’ve made adjustments to your IQOS investment plans here too. So is all of that baked into the guidance you laid out — and you also have substantial cost savings flowing through? Could you walk through those elements that are propping up Q2 earnings on top of the negative impacts you’re seeing?

Martin King

executive
#50

Yeah. The range for the Q2 figure that we provided is fully inclusive and takes in our best estimate regarding the cost and spending base, including added emphasis on digital and certain other areas where we can put money to work right now to assist us in retooling and to be able to bounce back faster. So that figure is fully inclusive, since it accounts for items like, yes, reduced travel, and other cost spending categories that simply aren’t occurring since people are working in a different way; it’s all captured in there. Yes.

André Calantzopoulos

executive
#51

Are you there?

Michael Lavery

analyst
#52

< > regarding IQOS. Also, I believe you actually mentioned digital demonstrations…

André Calantzopoulos

executive
#53

Could you please pause, since your question cut out right at the start?

Martin King

executive
#54

Michael, could you say that again? We lost part of what you were asking right at the start.

Michael Lavery

analyst
#55

Yes. My apologies. You brought up greater use of digital channels for IQOS. And I believe you also mentioned digital demonstrations. And I suppose I'd really like to get a sense of just how creative and adaptable you're able to be in that area. Are you talking about a situation where a device gets delivered or lent to the consumer so they can try it at home, or is it simply watching somebody do it online, or how should we think about just how robust your digital interaction can be?

André Calantzopoulos

executive
#56

Yes. We do lend out devices, clearly with extremely stringent hygiene protocols in place, since the devices are brand new. And after that, we conduct the guided trial through digital channels. The coaches, or the sales experts, work from their homes and instruct the consumers. At the moment, consumers might have a little extra time on their hands. So it's far simpler to carry this out than it would be under normal circumstances too. And that's the way we go about it. And I think I was taken aback that we kept up such a strong level. It could be a blessing, I'd say, since that benefits everyone — consumers on one hand, and our organization on the other, pushing us further and further into digital and teaching us during this crisis that plenty of tasks can be done remotely as well, learning while working from home, incidentally; so, that's a positive thing; and perhaps we can boost sales even more this way, which in time would let us streamline the infrastructure costs we carry; and we've simply received a push, I'd say, in a direction we were already heading regardless.

Michael Lavery

analyst
#57

All right, that’s useful. Just one additional question about IQOS. You said that in Russia and the EU, device prices were already lower during the previous quarter. Could you explain the steps you’ve implemented there, and are those price reductions temporary or permanent?

André Calantzopoulos

executive
#58

My apologies. I don’t believe we altered our device price; we ran some promotional activity…

Martin King

executive
#59

My sense is that looking at this on a year-over-year basis makes more sense, simply because during the back half of last year we made certain adjustments to device prices. However, at this point the comparison we're up against, and now lapping, is the first quarter of last year, before those adjustments had taken place. Once you get into the second half, my expectation is that device pricing will look considerably more stable relative to the same period a year earlier.

Michael Lavery

analyst
#60

All right, that's excellent. Many thanks.

Robert Rampton

analyst
#61

Hi there. I really appreciate you fielding my questions. There are two things I'd like to ask. First, regarding the revenue assumption you have for 2Q 2020 — could you tell us what that assumption had been previously? My understanding is that you said 1H would have come in at 5% ex-COVID, which as I figure it would suggest 3% for 2Q. Is that the right way to think about it? Thanks.

Martin King

executive
#62

Yes. For Q2, if you set aside the COVID effects, net revenue would have been essentially flat, maybe slightly up; however, the consequences of those other volume events I referenced — such as the Mexico comparison, the Turkey comparison, and what happened in Indonesia — were already going to drag our combined volumes down by roughly minus 5.5%, maybe 6%; as a result, net revenues would have ended up only marginally positive, not by much, but slightly positive, basically flat. So what you're now observing, with the COVID-related effects added on top, is something sitting on top of what was already a rather soft quarterly pace — one we had already signaled back at CAGNY and on the year-end call too. That covers the first quarter; so you need to view both quarters together and consider them in that light; that's the reason I said that if you take the average across the first two quarters, excluding the COVID effects, we were exactly where our guidance indicated, and honestly, even somewhat ahead.

Robert Rampton

analyst
#63

Understood, that makes a lot of sense. Then, looking further ahead, say for 2021 and 2022, ought we to anticipate higher excise taxes and possibly governments narrowing tax loopholes as they seek more revenue?

André Calantzopoulos

executive
#64

Well, none of that has shown up so far, clearly. Governments, I believe, will be hunting for funds, yet they're also aware that hiking taxes on a regular basis is the most effective route to bringing in the most money. And to be honest, when we consider the spending programs the world is promising to roll out, I doubt cigarettes could account for even an endless sliver of that. So, it's worth keeping an eye on — that much is certain — but as of today we see no indications of anything like this; that's all I can tell you right now.

Robert Rampton

analyst
#65

Excellent, thanks a lot.

Bonnie Herzog

analyst
#66

Thanks. Hello, everybody.

Martin King

executive
#67

Hey there, Bonnie.

André Calantzopoulos

executive
#68

Hello, Bonnie. I hope all is well with you.

Bonnie Herzog

analyst
#69

Yes, I'm fine, and I hope the same for all of you. I just wanted to get some clarity on a point you brought up much earlier during this call. You did address it. But I'd like to understand, regarding bringing in new IQOS users, whether — if you can reach consumers remotely and interact with them — you aren't observing any hesitation on their part about switching to IQOS under these circumstances; that's my first question. And second, if your efforts to bring in new IQOS users stay under pressure through the remainder of Q2, as you mentioned, I'm just trying to figure out how that plays out for your main cigarette business.

André Calantzopoulos

executive
#70

Well, on your first point, I haven't come across any variation in what we refer to as the adoption funnel. After someone is reached, our purchase rates tend to be quite high, since frequently the individuals who visit the stores or the digital platforms are those who already know about the product and are, honestly, already persuaded. And clearly, those who now arrive through our digital channels are the most persuaded; so in fact we might be seeing higher rates — I don't have the figures, we can follow up with you — than our previous average, which makes sense. Now, cigarettes are somewhat harder to forecast. Clearly, for IQOS, I can see the momentum is present. And as soon as we're able to restart direct interactions with people, we'll be back on course. Because I don't perceive any shift in that momentum. I'm actually quite struck that, during this period, considering where we stand in terms of new consumers moving to IQOS.If you examine cannibalization rates, naturally there would be reduced cannibalization when there's lower IQOS acquisition; but should that persist for a couple of months, I don't believe it will damage either one. Okay? The remainder is all the micro-level matters covered during the call, the short-term declines in average daily consumption in certain locations; and then of course it hinges on where the world ends up as this crisis concludes, we'll find out whether there's any longer-term recessionary effect. But as you're aware, cigarettes tend to hold up quite well against recession generally. So it's really a matter of the long-term picture, which frankly, for any of us today, is very hard to assess. Okay? But we aren't seeing any shifts in the dynamics.

Bonnie Herzog

analyst
#71

All right, that's useful. Then, perhaps I overlooked this, but is it fair to keep assuming that the 90 billion to 100 billion stick IQOS HTU volume goal remains realistic by 2021? I realize there is plenty of uncertainty, but are you still — I suppose, are you still putting that target forward?

André Calantzopoulos

executive
#72

Should the restrictions endure for the quarter, I believe we are fine. Should they endure for a year, clearly, the entire matter has to be pushed back by some period of time. The fundamental trajectory, I think, is intact. So, as things stand right now, that is my view.

Bonnie Herzog

analyst
#73

All right, and one last quick item from my side. Regarding what you spend on marketing, during this call you said you're making adjustments and putting additional funds toward the places where you expect the greatest return — likely digital. Still, I'd like to know the overall amount spent in 2020. My understanding is that you had an incremental target, was it $300 million to $350 million for this year. And with all that's happened, I'm simply wondering whether that figure has shifted at all?

André Calantzopoulos

executive
#74

Well, at this moment, that quarterly investment has slowed somewhat, clearly, since not every opportunity is open to us. And clearly, we retain flexibility since it's variable; at this point, we must wait and see when the crisis ends and whether we should double the Q1 resources for some stretch of time to make up ground, and whether that is justified from an investment standpoint; so flexibility exists on our side. Should no opportunity arise, we won't deploy the full sum; and clearly, it will roll into next year. That's my view. Right now, spending is slower, clearly. The distinction is that in spite of the added digital investment, which is money being reallocated.

Bonnie Herzog

analyst
#75

Okay. Thank you so much.

André Calantzopoulos

executive
#76

Thank you, Bonnie.

André Calantzopoulos

executive
#77

All right. Thanks, everyone, for being on this call. I realize that these are unusual times for each of us. What I'd like to say is that we see no issues with the basics of our business — in fact, those basics are still quite robust. My view is that all of this is short-lived, yet what's short-lived here is the unpredictability itself; we've made an effort to be maximally open and to provide as much detail as we possibly can. On the whole, I think that when it comes to the PMI operations, we're doing reasonably well, all things considered. And my hope is that we exit this crisis as quickly as we can, so that we get back to business. Yet on the whole, I think that for me, the longer-term picture is — it stays the same, which is very encouraging. And in the near term, we're strongly dedicated to ensuring that our operations keep running and that our employees stay safe. And I think we've performed well on that front, since that is what will leave our business in a stronger position once we emerge from this crisis. So, we'll continue to keep you informed. As I mentioned, we have the shareholders meeting. Should anything come up, we'll tell you. And please be patient with us during this stretch of unpredictability.

Nick Rolli

executive
#78

André, if you'll allow me, I'd like to close with one last thing. Everyone should be aware that this marks Martin's final earnings call in the Chief Financial Officer seat. Most of you are probably already aware that he's moving into a new position as CEO of PMI America. So I believe I can speak on behalf of the entire company at PMI — and definitely the finance team that interacts with him every single day — in saying thank you for his dedication, his hard work, and that great sense of humor of his. That's something we're going to miss. At the same time, we're excited to bring Emmanuel Babeau on board as our incoming CFO effective May 1st, and he'll be with us on these calls going forward. So congratulations, Martin, and wishing you the very best.

Martin King

executive
#79

Thanks a lot, Nick.

Nick Rolli

executive
#80

That wraps up today's call. Thanks so much. Should any follow-up questions come up, please get in touch with the Investor Relations team. Thank you. Stay well, stay healthy.

Operator

operator
#81

Thanks. Everyone, that brings us to the end of today's call. You're free to hang up now.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Philip Morris International Inc. transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to Philip Morris International Inc. earnings transcripts and 132,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Philip Morris International Inc. or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.